Revolutionizing Pediatric Care: Approval of Mal...

By João L. Carapinha

July 10, 2025

Novartis recently announced that it has received approval for the first malaria medicine for newborns, specifically developed for babies and young infants. This groundbreaking development targets a vulnerable population that has historically had l...
10-Year Health Plan: Transforming England’s NHS for the Future
EU Life Sciences Strategy: Paving the Way for Europe’s Leadership by 2030
Ticagrelor Data Integrity Under Fire: Scrutiny Reveals Flaws in Key Clinical ...
The Value of Self-Care in Public Health: Insights and Implications for Europe
Pharma Ad Spending Trends: Insights from the Top 10 Drug Advertisers of 2024
Dutch Health Disruption: Reimagining Care with Social Entrepreneurship
Pharmaceutical Industry Europe: Key Insights and Future Challenges for 2025
Streamlining Prior Authorization Reforms: Impacts and Insights for HEOR
Private Health Funding Under South Africa’s National Health Insurance Act
Impending Net Drug Price Transparency Regulation in the U.S.
Transparency in Industry Partnerships: Building Trust
DALY Modeling Methods for Enhanced Health Economics and Policy Analysis